Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Hartmut Döhner, Andre C. Schuh, Christian Recher, Jenny O’Nions, Ibrahim Aldoss, Ana Alfonso Piérola, Alicia Jones Allred, Juan Manuel Alonso-Dominguez, Laura Barreyro, Pierre Bories, Nikki Daskalakis, Matteo G. Della Porta
+39 more Amber D’Souza, James Dugan, Jordi Esteve, Amir T. Fathi, Lucille A. Ferrante, Stan Gaj, Sylvain Garciaz, Ana Garrido Diaz, Olga Salamero, Christina Drenberg Guttke, Emmanuel Kofi Gyan, Brett M. Hiebert, Elias Jabbour, Madlen Jentzsch, Hagop M Kantarjian, Marina Konopleva, Jan Krönke, Marie Luise Hütter‐Krönke, Christina Loefgren, Oliver Lomas, Valentina Mancini, Ioannis Mantzaris, Daniel Morillo, Kathryn E. Packman, Cristina Papayannidis, Ulrike Philippar, Uwe Platzbecker, Sara Garrido Paniagua, Naa Sackey, Tim Sauer, Prathap Nagaraja Shastri, Emma J Searle, Natalia Tovar, Danielle Trancucci, Nicolas Vallet, Lachlin Vaughan, Paresh Vyas, Andrew H. Wei, Christoph Röllig
DOI: 10.1016/j.jtct.2025.12.560
Cited by: 1

Fields of Study & Subjects

Acute Myeloid Leukemia Research Chronic Myeloid Leukemia Treatments Myeloproliferative Neoplasms: Diagnosis and Treatment

Publication details

Journal / source
Transplantation and Cellular Therapy
Publisher
Elsevier BV
Volume
32
Issue
2
Pages
S390–S391
Publication date
1 February 2026
Language
EN